Ovarian Neoplasm
Showing NaN - NaN of 6
Ovarian Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial run by the NCI (Bevacizumab, BAY 43-9006)
Completed
- Ovarian Neoplasm
- +2 more
- Bevacizumab
- BAY 43-9006
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020
Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Completed
- Breast Carcinoma
- +3 more
- Evaluation of Cancer Risk Factors
- +3 more
-
Birmingham, Alabama
- +140 more
Aug 31, 2020
Test in Ovarian Cancer Remission to See if Protein Changes Can
Completed
- Ovarian Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 11, 2020
Family Communication of Hereditary Breast and Ovarian Cancer
Terminated
- Ovarian Neoplasm
- +2 more
-
Bethesda, MarylandNational Human Genome Research Institute (NHGRI), 9000 Rockville
Nov 30, 2019
Ovarian Tumor Trial run by the NCI (Cyclophosphamide, Paclitaxel, Cisplatin)
Completed
- Ovarian Neoplasm
- Cyclophosphamide
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 4, 2018
Ovarian Tumor Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, p53 peptide vaccine)
Terminated
- Ovarian Neoplasm
- aldesleukin
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2017